蔚蓝生物
(603739)
| 流通市值：32.51亿 | | | 总市值：32.51亿 |
| 流通股本：2.53亿 | | | 总股本：2.53亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 709,615,819.06 | 345,050,139.43 | 1,366,123,678.63 | 1,015,793,037.32 |
| 营业总成本 | 657,262,341.14 | 319,210,567.09 | 1,281,214,678.35 | 946,888,887.21 |
| 其他经营收益 | | | | |
| 营业利润 | 69,282,509.43 | 32,229,451.22 | 127,591,514.41 | 109,555,137.2 |
| 利润总额 | 68,841,181.97 | 32,230,638.1 | 123,705,917.89 | 108,383,832.31 |
| 净利润 | 53,339,740.57 | 25,451,987.04 | 97,465,510.65 | 82,929,836.08 |
| 每股收益 | | | | |
| 其他综合收益 | 83,086.88 | -480,627.11 | 224,554.39 | -219,343.11 |
| 综合收益总额 | 53,422,827.45 | 24,971,359.93 | 97,690,065.04 | 82,710,492.97 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,238,497,042.31 | 1,237,984,214.11 | 1,178,619,183.05 | 1,149,287,280.25 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,777,420,232.59 | 1,838,151,794.92 | 1,861,040,116.27 | 1,892,244,394.66 |
| 资产总计 | 3,015,917,274.9 | 3,076,136,009.03 | 3,039,659,299.32 | 3,041,531,674.91 |
| 流动负债: | | | | |
| 流动负债合计 | 1,001,979,826.98 | 1,040,557,660.1 | 1,007,084,872.41 | 1,063,345,832.14 |
| 非流动负债: | | | | |
| 非流动负债合计 | 105,248,360.93 | 109,466,269.3 | 121,854,811.89 | 76,983,738.82 |
| 负债合计 | 1,107,228,187.91 | 1,150,023,929.41 | 1,128,939,684.3 | 1,140,329,570.96 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,795,784,289.24 | 1,799,752,986.63 | 1,782,521,319.49 | 1,774,027,009.24 |
| 股东权益合计 | 1,908,689,086.99 | 1,926,112,079.62 | 1,910,719,615.02 | 1,901,202,103.95 |
| 负债和股东权益合计 | 3,015,917,274.9 | 3,076,136,009.03 | 3,039,659,299.32 | 3,041,531,674.91 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 770,336,343.66 | 405,531,124.49 | 1,440,086,388.67 | 1,088,277,035.44 |
| 经营活动现金流出小计 | 714,042,170.12 | 387,268,536.2 | 1,326,138,907.28 | 1,054,520,263.63 |
| 经营活动产生的现金流量净额 | 56,294,173.54 | 18,262,588.29 | 113,947,481.39 | 33,756,771.81 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 269,104,608.55 | 76,673,189.59 | 925,038,804.92 | 679,521,360.27 |
| 投资活动现金流出小计 | 258,632,195.67 | 114,965,272.91 | 999,633,710.05 | 721,034,075.45 |
| 投资活动产生的现金流量净额 | 10,472,412.88 | -38,292,083.32 | -74,594,905.13 | -41,512,715.18 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 335,703,216.66 | 136,660,015.22 | 754,723,029.39 | 530,553,730.79 |
| 筹资活动现金流出小计 | 415,389,326.25 | 134,189,861.55 | 792,185,784.78 | 560,203,638.7 |
| 筹资活动产生的现金流量净额 | -79,686,109.59 | 2,470,153.67 | -37,462,755.39 | -29,649,907.91 |
| 汇率变动对现金及现金等价物的影响 | - | - | -177,201.94 | - |
| 现金及现金等价物净增加额 | -12,919,523.17 | -17,559,341.36 | 1,712,618.93 | -37,405,851.28 |
| 期末现金及现金等价物余额 | 222,119,554.08 | 217,479,735.89 | 235,039,077.25 | 195,920,607.04 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -12,919,523.17 | - | 1,712,618.93 | - |
最新报告期：2026-09-01| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 国信证券 | 李瑞楠,江海航,鲁家瑞 | 0.38 | 0.40 | 0.40 | 2026-09-01 |
| 西南证券 | 徐卿 | 0.32 | 0.35 | 0.47 | 2026-08-28 |